Human papillomavirus, current vaccines, and cervical cancer prevention

Anne M. Teitelman, Marilyn Stringer, Tali Averbuch, Amy Witkoski

Research output: Contribution to journalArticlepeer-review


Human papillomavirus infection, the most common sexually transmitted infection in the United States, is associated with the development of cervical cancer. The new human papillomavirus vaccine advances cervical cancer prevention; however, provider-recommended screening with Papanicolaou tests and lifestyle modifications are still needed. Widespread implementation of the vaccine and delivering cervical cancer screening to underserved populations remain a challenge. Nurses are ideally suited to address these needs by providing education to patients and families.

Original languageEnglish (US)
Pages (from-to)69-80
Number of pages12
JournalJOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing
Issue number1
StatePublished - 2009


  • Adolescent females
  • Cervical cancer
  • Human papillomavirus (HPV)
  • Papanicolaou(Pap) tests
  • Parent-adolescent communication
  • Patient education
  • Prevention
  • Sexual risk
  • Sexually transmitted infection
  • Vaccines

ASJC Scopus subject areas

  • Pediatrics
  • Critical Care
  • Maternity and Midwifery


Dive into the research topics of 'Human papillomavirus, current vaccines, and cervical cancer prevention'. Together they form a unique fingerprint.

Cite this